CNBC · 1 min read

AstraZeneca slides after report of Bristol Myers merger talks leaves analysts 'perplexed'

AstraZeneca slides after report of Bristol Myers merger talks leaves analysts 'perplexed'

The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.

This is a summary aggregated from CNBC. Read the complete article on the original site:

Read full article at CNBC

More Business & Finance News